חזרה לתוצאות החיפוש

A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Smoking

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Woodland Research Northwest, Rogers, Arkansas, United States

    Contact: Principal Investigator (Timothy Cook)

  • Hillcrest Medical Research, DeLand, Florida, United States

  • TecTum Research, Hollywood, Florida, United States

    Study coordinator · 954-990-7649
    Contact: Principal Investigator (Juan Rondon)

  • K2 Medical Research ORLANDO, Maitland, Florida, United States

    Study coordinator · 407-500-5252
    Contact: Principal Investigator (Brandon Lenox)

  • GTL Medical & Research Group, Miami, Florida, United States

    Contact: Principal Investigator (Dunia Llapur Hernandez)

  • North Georgia Clinical Research, Woodstock, Georgia, United States

    Study coordinator · 678-494-5735
    Contact: Principal Investigator (Bram Wieskopf)

  • Revival Research Institute, LLC, Dearborn, Michigan, United States

    Study coordinator · 586-276-7453
    Contact: Principal Investigator (Abdulhassan Saad)

  • Arch Clinical Trials, St Louis, Missouri, United States

    Contact: Principal Investigator (Kulsoom Junaid)

  • Vector Clinical Trials, Las Vegas, Nevada, United States

    Study coordinator · 702-750-0000
    Contact: Principal Investigator (Ann Childress)

  • Rochester Clinical Research, LLC, Rochester, New York, United States

    Study coordinator · 585-288-0890
    Contact: Principal Investigator (Leigh Schirmer)

  • Coastal Carolina Research Center, North Charleston, South Carolina, United States

    Study coordinator · 843-352-6977
    Contact: Principal Investigator (Rica Santiago)

  • Circle Clinical Research, Sioux Falls, South Dakota, United States

    Study coordinator · 605-215-1159
    Contact: Principal Investigator (Sophie Two Hawk)

  • FutureSearch Trials of Dallas, Dallas, Texas, United States

    Study coordinator · 214-369-2600
    Contact: Principal Investigator (Michael Downing)

  • The University of Texas Health Science Center at Houston, Houston, Texas, United States

    Study coordinator · 832-776-3151
    Contact: Principal Investigator (Luba Yammine)

  • Health Research of Hampton Roads, Inc., Newport News, Virginia, United States

    Study coordinator · 757-591-8100
    Contact: Principal Investigator (George Freeman)

  • Eastside Research Associates, Redmond, Washington, United States

    Study coordinator · 425-869-6828
    Contact: Principal Investigator (Chad Crystal)

  • Beijing Chaoyang Hospital, Capital Medical University, Beijing, China

    Contact: Principal Investigator (Lirong Liang)

  • Beijing Anding Hospital - Affiliated Capital University of Medical Science, Beijing, China

    Contact: Principal Investigator (Anning Li)

  • Sichuan Provincial People's Hospital, Chengdu, China

    Contact: Principal Investigator (Haiying Yan)

  • 2nd Affiliated Hospital Chongqing Medical University, Chongqing, China

    Study coordinator · 13452414579
    Contact: Principal Investigator (Na Li)

  • Sir Run Run Shaw Hospital of Zhejiang University School of Medicine, Hangzhou, China

    Contact: Principal Investigator (Jinsong Tang)

  • Taizhou Hospital of Zhejiang Province, Linhai, China

    Contact: Principal Investigator (Dongqing LV)

  • The first affiliated hospital of Ningbo university, Ningbo, China

    Contact: Principal Investigator (Yunxin Ji)

  • The University of Hong Kong-Shenzhen Hospital, Shenzhen, China

    Contact: Principal Investigator (Lei Rong)

  • Miyazaki RC Clinic, Shinagawa-ku, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Masaki Miyazaki)

  • Samoncho Clinic, Shinjuku, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Takahiro Yokoyama)

  • Higashi Shinjuku Clinic, Tokyo, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Hiroaki Kondo)
מובילי המחקר

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)

    Study Director

    Eli Lilly and Company

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)